PMDA drug package insert
新コンタックせき止めダブル持続性
PMDA OTC drug · Haleonジャパン株式会社 · package insert Apr 30, 2026
Key facts
| Brand names | 新コンタックせき止めダブル持続性 |
|---|---|
| Companies | 製造販売元／Haleonジャパン株式会社 |
| Product type | OTC drug |
| OTC risk class | 第２類医薬品 |
| OTC dosage form | カプセル |
| OTC effect category | 鎮咳去痰薬 |
| Package insert date | Apr 30, 2026 |
| PMDA document key | 252127_K1703000073 |
| PMDA company code | 252127 |
At a glance
- 1–9 Package insert revisions
- None Related PMDA documents
- None Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: